Douglas L Badders

Title: Innovations and Contributions of Inventor Douglas L Badders

Introduction: Douglas L Badders is a notable inventor based in Seattle, WA, recognized for his impactful contributions to the field of biotechnology. With a portfolio of four patents, he has made significant advancements, particularly involving Trp cage polypeptides and their applications.

Latest Patents: One of Douglas' latest patents is focused on "Phage displayed Trp cage ligands," which discloses the Trp cage binding domains that possess the generic formulae of SEQ ID NO: 2, 7, 10, or 11. These binding domains can be efficiently produced and screened using phage display technology. Another significant patent is entitled "Phage displayed cell binding peptides," which provides insights into the construction, expression, and selection of mutated genes encoding novel Trp cage polypeptides. These polypeptides exhibit desirable binding properties and can target a variety of biological and synthetic macromolecules, including proteins and other organic or inorganic substances.

Career Highlights: Throughout his career, Douglas has worked with leading companies in the biotechnology sector, including Moderna, Inc. and Marina Biotech, Inc. His experiences in these organizations have contributed to his understanding and innovation in the development of binding polypeptides.

Collaborations: Throughout his career, Douglas has collaborated with esteemed colleagues, including Richard E. Herman and Ekaterina G. Makienko. Their joint efforts have fostered a creative environment that has led to groundbreaking developments in biotechnology.

Conclusion: Douglas L Badders stands out as an influential figure within the innovation landscape, particularly in the realm of biotechnological advancements. His patents reflect a commitment to enhancing our understanding of polypeptides and their potential applications, demonstrating the profound impact that dedicated inventors like him can have in shaping the future of science and technology.